RxDoctor Payments Data

Eva Rzucidlo, MD

Vascular Surgery · Florence, SCNPI 1699787523

Payments from drug & device makers

$4,111in general payments, 2019–2025

Across 105 payments — averaging $39.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$703
  • Endologix LLC$581
  • Cardiovascular Systems Inc.$580
  • Boston Scientific$322
  • Musculoskeletal Transplant Foundation Inc.$289
  • Organogenesis Inc.$203
  • plus $1K from 31 others

What the payments were for

  • Travel & lodging$97024%
  • Food & beverage$3,14076%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,111 in reported general payments places this provider in the 25th percentile of 99 vascular surgery providers in South Carolina.

See all vascular surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$338,170
Medicare patients
1,302
Services billed
2,250

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate162$2,633
Cilostazol60$1,162
Rosuvastatin Calcium16$189
Atorvastatin Calcium18$132

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →